[Position statement of the (Hungarian) College of Oncology and Radiotherapy regarding the health insurance reimbursement for Emend(aprepitant)]

Magy Onkol. 2009 Mar;53(1):81-2. doi: 10.1556/MOnkol.53.2009.1.12.
[Article in Hungarian]
No abstract available

Publication types

  • Guideline

MeSH terms

  • Antiemetics / economics*
  • Antiemetics / therapeutic use
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Aprepitant
  • Humans
  • Hungary
  • Insurance, Health, Reimbursement / standards*
  • Medical Oncology
  • Morpholines / economics*
  • Morpholines / therapeutic use
  • Nausea / chemically induced
  • Nausea / drug therapy*
  • Selective Serotonin Reuptake Inhibitors / economics
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Societies, Medical
  • Vomiting / chemically induced
  • Vomiting / drug therapy*

Substances

  • Antiemetics
  • Antineoplastic Agents
  • Morpholines
  • Serotonin Uptake Inhibitors
  • Aprepitant